Shuai Mao

1.8k total citations
61 papers, 1.5k citations indexed

About

Shuai Mao is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Shuai Mao has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Organic Chemistry, 23 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Shuai Mao's work include Catalytic C–H Functionalization Methods (20 papers), Quinazolinone synthesis and applications (10 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Shuai Mao is often cited by papers focused on Catalytic C–H Functionalization Methods (20 papers), Quinazolinone synthesis and applications (10 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Shuai Mao collaborates with scholars based in China, United States and Australia. Shuai Mao's co-authors include Yong‐Qiang Wang, Yaru Gao, San‐Qi Zhang, Dong‐Dong Guo, Minhang Xin, Yanlei Zhang, Wenliang Chen, Xue‐Qing Zhu, Pengfei Li and Yufei Wang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Shuai Mao

60 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuai Mao China 23 1.0k 399 166 145 114 61 1.5k
Hongqi Tian China 21 606 0.6× 485 1.2× 244 1.5× 249 1.7× 219 1.9× 52 1.5k
Thomas M. McGuire United Kingdom 25 1.1k 1.1× 490 1.2× 174 1.0× 214 1.5× 78 0.7× 53 1.9k
Chunpu Li China 25 941 0.9× 723 1.8× 119 0.7× 197 1.4× 67 0.6× 78 1.8k
Steven T. Staben United States 22 2.2k 2.1× 617 1.5× 386 2.3× 147 1.0× 64 0.6× 33 2.8k
D. Allen Annis United States 19 430 0.4× 863 2.2× 180 1.1× 269 1.9× 168 1.5× 26 1.4k
Ziyuan Li China 20 682 0.7× 474 1.2× 99 0.6× 105 0.7× 231 2.0× 83 1.5k
Lara Massai Italy 26 847 0.8× 625 1.6× 156 0.9× 1.0k 7.1× 296 2.6× 88 1.9k
Arthur D. Tinoco Puerto Rico 21 253 0.2× 282 0.7× 207 1.2× 411 2.8× 238 2.1× 40 1.1k
Shabnam Shaabani Iran 22 670 0.6× 515 1.3× 57 0.3× 283 2.0× 201 1.8× 58 1.3k

Countries citing papers authored by Shuai Mao

Since Specialization
Citations

This map shows the geographic impact of Shuai Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Mao more than expected).

Fields of papers citing papers by Shuai Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Mao. The network helps show where Shuai Mao may publish in the future.

Co-authorship network of co-authors of Shuai Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai Mao. A scholar is included among the top collaborators of Shuai Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai Mao. Shuai Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Hongyi, Zhongwei Liu, Jinsong Tao, et al.. (2025). An oral tricyclic STING agonist suppresses tumor growth through remodeling of the immune microenvironment. Cell chemical biology. 32(2). 280–290.e14. 3 indexed citations
2.
Li, Yiyang, Yannan Qin, Yi Liu, et al.. (2025). Transfersome enhances nail penetration of antifungal drug and photosensitizer for chemo-photodynamic therapy of onychomycosis in a novel rat model. Journal of Controlled Release. 385. 114029–114029. 1 indexed citations
3.
Li, Chengyi, Shuai Mao, Alejandro Balsa, et al.. (2025). SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation. ACS Nano. 19(7). 7038–7054. 3 indexed citations
5.
Chen, Zheng, Xinwei Guan, Zihang Huang, et al.. (2024). Inhibiting irreversible Zn2+/H+ co-insertion chemistry in aqueous zinc-MoO batteries for enhanced capacity stability. Journal of Energy Chemistry. 102. 98–106. 5 indexed citations
6.
Mao, Shuai, Xu Han, Zihang Huang, Hui Li, & Tianyi Ma. (2024). Coordination and Hydrogen Bond Chemistry in Tungsten Oxide@Polyaniline Composite toward High‐Capacity Aqueous Ammonium Storage. Small. 20(51). e2405592–e2405592. 11 indexed citations
7.
Tao, Xuewen, Shuai Mao, Cailin Xue, et al.. (2024). SEC24C suppresses the propagation and chemoresistance of hepatocellular carcinoma by promoting unfolded protein response-related apoptosis. BioScience Trends. 18(4). 343–355. 1 indexed citations
8.
Zhao, Hongyi, Zhongwei Liu, Shuai Mao, et al.. (2024). Abstract 4475: Discovery of an oral tricyclic STING agonist with superior pharmacokinetic properties and potent in vivo efficacy. Cancer Research. 84(6_Supplement). 4475–4475.
9.
Wu, Pengkai, Haitian Zhang, Yin Yin, et al.. (2022). Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy. Advanced Science. 9(15). e2105894–e2105894. 30 indexed citations
10.
Wu, Pengkai, Haitian Zhang, Shuai Mao, et al.. (2022). Manipulating Offense and Defense Signaling to Fight Cold Tumors with Carrier‐Free Nanoassembly of Fluorinated Prodrug and siRNA. Advanced Materials. 34(38). e2203019–e2203019. 43 indexed citations
11.
Zhang, San‐Qi, et al.. (2021). Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia. Journal of Medicinal Chemistry. 64(21). 15519–15533. 14 indexed citations
12.
Huddle, Brandt C., Edward Grimley, Cameron D. Buchman, et al.. (2020). Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy. European Journal of Medicinal Chemistry. 211. 113060–113060. 13 indexed citations
13.
Yang, Xueyan, Ruizhe Wang, Lu Wang, et al.. (2020). K2S2O8-promoted C–Se bond formation to construct α-phenylseleno carbonyl compounds and α,β-unsaturated carbonyl compounds. RSC Advances. 10(48). 28902–28905. 9 indexed citations
14.
Zhang, Hao, Hongyi Zhao, Yanjie Liu, et al.. (2020). Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC). European Journal of Medicinal Chemistry. 189. 112061–112061. 97 indexed citations
15.
Wang, Huiyan, et al.. (2017). Discovery of 2-(pyridin-2-yl)aniline as a directing group for the sp2 C–H bond amination mediated by cupric acetate. Organic & Biomolecular Chemistry. 15(31). 6622–6631. 12 indexed citations
16.
Zhu, Xue‐Qing, Shuai Mao, Dong‐Dong Guo, et al.. (2016). Copper‐Catalyzed Isomerization and Cyclization of E/Zo‐Haloaryl N‐Sulfonylhydrazones: Convenient Access to 1H‐Indazoles. ChemCatChem. 9(6). 1084–1091. 16 indexed citations
17.
Zhang, Sai, Sai Zhang, Shuai Mao, et al.. (2015). Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents. Bioorganic & Medicinal Chemistry. 24(2). 179–190. 19 indexed citations
18.
Zhang, Hao, et al.. (2015). Synthesis and antitumor activity evaluation of PI3K inhibitors containing 3-substituted quinazolin-4(3H)-one moiety. Bioorganic & Medicinal Chemistry. 23(24). 7765–7776. 22 indexed citations
19.
Li, Sen, et al.. (2015). Discovery of novel 2-benzylisoquinolin-1(2H)-ones as potent vasodilative agents. Bioorganic & Medicinal Chemistry Letters. 25(24). 5808–5812. 4 indexed citations
20.
Zhang, Haibin, et al.. (2013). [Comparative study of wild and cultivated product of Panax japonicus from the west of Hubei province].. PubMed. 36(2). 171–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026